Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × plitidepsin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1

Conditions

Recurrence 1 Neoplasm Metastasis 1 Liposarcoma 1

Interventions

Cyclophosphamide 24 Temozolomide 22 Doxorubicin 20 Radiotherapy 17 Filgrastim 16 Ifosfamide 13 Etoposide 13 Gemcitabine 12 Cisplatin 12 pazopanib 11 Irinotecan 11 Imatinib Mesylate 11 Bevacizumab 11 Carboplatin 10 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 Rituximab 8 Radiation 8 Docetaxel 8 Cyclosporine 8 fludarabine phosphate 7 Vincristine 7 Methotrexate 7 Melphalan 7 Busulfan 7 Antilymphocyte Serum 7 pembrolizumab 6 fludarabine 6 Radiotherapy, Intensity-Modulated 6 Paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡